Project for Immunogenomics;
Cancer Precision Medicine Center;
Japanese Foundation for Cancer Research;
Tokyo 135-8550;
Japan;
Personalized medicine; cancer precision medicine; neoantigen; personalized immunotherapy; immune checkpoint blockade; cancer vaccine; adoptive T cell therapy;